These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4789 related items for PubMed ID: 3743866

  • 1. Quantitative evaluation of anticancer agents against human melanoma cells implanted in nude mice.
    Lockshin A, Giovanella BC, Stehlin JS.
    Exp Cell Biol; 1986; 54(3):149-54. PubMed ID: 3743866
    [Abstract] [Full Text] [Related]

  • 2. Exceptional lethality for nude mice of cells derived from a primary human melanoma.
    Lockshin A, Giovanella BC, De Ipolyi PD, Williams LJ, Mendoza JT, Yim SO, Stehlin JS.
    Cancer Res; 1985 Jan; 45(1):345-50. PubMed ID: 3965144
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of anticancer drugs determined in nude mice inoculated with [125I]5-iodo-2'-deoxyuridine-prelabeled human melanoma cells.
    Lockshin A, Giovanella BC, Vardeman DM, Mendoza JT, Quian C, Kozielski T, Stehlin JS.
    J Natl Cancer Inst; 1985 Apr; 74(4):899-903. PubMed ID: 3921748
    [Abstract] [Full Text] [Related]

  • 4. Hyaluronidase pretreatment produces selective melphalan enrichment in malignant melanoma implanted in nude mice.
    Muckenschnabel I, Bernhardt G, Spruss T, Buschauer A.
    Cancer Chemother Pharmacol; 1996 Apr; 38(1):88-94. PubMed ID: 8603457
    [Abstract] [Full Text] [Related]

  • 5. The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts.
    Boven E, Jansen WJ, Hulscher TM, Beijnen JH, van Tellingen O.
    Eur J Cancer; 1999 May; 35(5):840-9. PubMed ID: 10505047
    [Abstract] [Full Text] [Related]

  • 6. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M, Altermatt HJ, Ris HB, Althaus U, Rüegg C, Liénard D, Lejeune FJ.
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [Abstract] [Full Text] [Related]

  • 7. Prediction of anticancer activity by tumor uptake of radiolabeled monoclonal antibody.
    Lockshin A, Kozielski T, Stehlin JS.
    Cancer Lett; 1986 Jan; 30(1):1-9. PubMed ID: 3943076
    [Abstract] [Full Text] [Related]

  • 8. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD, Millar JL, McElwain TJ.
    Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
    [Abstract] [Full Text] [Related]

  • 9. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
    Rosenberg MC, Colvin OM, Griffith OW, Bigner SH, Elion GB, Horton JK, Lilley E, Bigner DD, Friedman HS.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6917-22. PubMed ID: 2582434
    [Abstract] [Full Text] [Related]

  • 10. Correlation between response to chemotherapy of human tumors in patients and in nude mice.
    Giovanella BC, Stehlin JS, Shepard RC, Williams LJ.
    Cancer; 1983 Oct 01; 52(7):1146-52. PubMed ID: 6883283
    [Abstract] [Full Text] [Related]

  • 11. Antitumor effect of human fibroblast interferon on the growth of human melanoma cells implanted in nude mice.
    Ida N, Uenishi N, Kajita A, Satoh Y.
    Gan; 1982 Dec 01; 73(6):952-60. PubMed ID: 7160584
    [Abstract] [Full Text] [Related]

  • 12. A nude rat model for neutron capture therapy of human intracerebral melanoma.
    Barth RF, Matalka KZ, Bailey MQ, Staubus AE, Soloway AH, Moeschberger ML, Coderre JA, Rofstad EK.
    Int J Radiat Oncol Biol Phys; 1994 Mar 30; 28(5):1079-88. PubMed ID: 8175392
    [Abstract] [Full Text] [Related]

  • 13. Effect of five antineoplastic agents on tumor xenografts with different growth rates.
    Mattern J, Wayss K, Volm M.
    J Natl Cancer Inst; 1984 Jun 30; 72(6):1335-9. PubMed ID: 6587154
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo enhancement of vincristine antitumor activity on B16 melanoma cells by calcium antagonist flunarizine.
    Bellelli A, Camboni C, de Luca G, Materazzi M, Mattioni M, Sezzi ML, Bellelli L.
    Oncology; 1987 Jun 30; 44(1):17-23. PubMed ID: 3561923
    [Abstract] [Full Text] [Related]

  • 15. Correlation of cytotoxicity with elimination of iodine-125 from nude mice inoculated with prelabeled human melanoma cells.
    Lockshin A, Giovanella BC, Quian C, Mendoza JT, Vardeman DM, Stehlin JS.
    J Natl Cancer Inst; 1984 Aug 30; 73(2):417-22. PubMed ID: 6589433
    [Abstract] [Full Text] [Related]

  • 16. Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard.
    Horton JK, Houghton PJ, Houghton JA.
    Cancer Res; 1987 Dec 01; 47(23):6288-93. PubMed ID: 2890432
    [Abstract] [Full Text] [Related]

  • 17. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
    Gao L, Chen L, Fei XH, Qiu HY, Zhou H, Wang JM.
    Chin Med J (Engl); 2006 Jun 05; 119(11):911-8. PubMed ID: 16780770
    [Abstract] [Full Text] [Related]

  • 18. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
    Taetle R, Rosen F, Abramson I, Venditti J, Howell S.
    Cancer Treat Rep; 1987 Mar 05; 71(3):297-304. PubMed ID: 3815395
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    Nath K, Nelson DS, Putt ME, Leeper DB, Garman B, Nathanson KL, Glickson JD.
    PLoS One; 2016 Mar 05; 11(6):e0157125. PubMed ID: 27285585
    [Abstract] [Full Text] [Related]

  • 20. A model of human cancer metastasis: extensive spontaneous and artificial metastasis of a human pigmented melanoma and derived variant sublines in nude mice.
    Kerbel RS, Man MS, Dexter D.
    J Natl Cancer Inst; 1984 Jan 05; 72(1):93-108. PubMed ID: 6582307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 240.